2009
DOI: 10.1016/j.taap.2009.07.012
|View full text |Cite
|
Sign up to set email alerts
|

Cytochrome P450-dependent toxic effects of primaquine on human erythrocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
62
0
1

Year Published

2010
2010
2022
2022

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 64 publications
(65 citation statements)
references
References 35 publications
2
62
0
1
Order By: Relevance
“…PQ requires metabolic activation for its antiparasitic activity and toxic effects (22). Deamination of the primary amino group of the side chain by monoamine oxidase (MOA) and hydroxylation of the quinoline ring by CYP enzymes have been identified as the two major metabolic pathways of PQ in in vitro (22,23) and in vivo (24) systems. Even though the aldehyde, the deamination product of PQ by MOA, has not been detected, its oxidized product carboxyprimaquine has been identified as the major circulating metabolite of racemic PQ in humans (25) and animals (26,27).…”
Section: Discussionmentioning
confidence: 99%
“…PQ requires metabolic activation for its antiparasitic activity and toxic effects (22). Deamination of the primary amino group of the side chain by monoamine oxidase (MOA) and hydroxylation of the quinoline ring by CYP enzymes have been identified as the two major metabolic pathways of PQ in in vitro (22,23) and in vivo (24) systems. Even though the aldehyde, the deamination product of PQ by MOA, has not been detected, its oxidized product carboxyprimaquine has been identified as the major circulating metabolite of racemic PQ in humans (25) and animals (26,27).…”
Section: Discussionmentioning
confidence: 99%
“…Si bien el perfil metabĂłlico de PQ no se ha dilucidado en su totalidad, sus metabolitos provocarĂ­an una lisis parasitaria por medio de radicales libres del oxĂ­geno y disrupciĂłn en la cadena respiratoria 4 . Asimismo, estos productos metabĂłlicos se asocian a los efectos adversos hematolĂłgicos como metahemoglobinemia 19 y anemia hemolĂ­tica en pacientes con dĂ©ficit de la enzima glucosa-6P-deshidrogenasa 20 . Por otra parte, el metabolismo del hospedero podrĂ­a interferir con la eficacia de la PQ.…”
Section: Discussionunclassified
“…Formation of methemoglobin by primaquine increased at least 10 times by coincubating red cells with human liver microsomes, and this metabolic conversion could also be accomplished by recombinant human CYPs 1A2, 3A4, 2D6, 2B6, and 2E1. 27 Inhibitors of CYPs 2B6, 2D6, and 3A4 caused significant inhibition of the methemoglobin formation mediated by the microsomes.…”
mentioning
confidence: 98%